{"entity":{"type":"insider","cik":"0001741850","url":"/insider/0001741850","json_url":"/insider/0001741850.json","name":"KREHER NERISSA","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":10,"first":"2022-09-12","last":"2025-06-23","span_basis":"filed_date"},"name_variants":[{"name":"KREHER NERISSA","source":"filing","n_filings":10,"first_seen":"2022-09-12","last_seen":"2025-06-23"}],"transactions":[{"id":5105155,"accession":"0000912282-25-000699","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000912282-25-000699","line_url":"/filing/0000912282-25-000699#line-1","is_derivative":false,"issuer_cik":"0001509261","issuer_name":"Rezolute, Inc.","issuer_ticker":"RZLT","issuer_name_source":null,"issuer_url":"/issuer/0001509261","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3076.0,"shares_display":"3,076","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":9997.0,"total_display":"9,997.00","total_whole":"9,997","shares_owned_after":37576.0,"shares_owned_after_display":"37,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-13","filed_date":"2025-06-23","scope":"insider"},{"id":8453217,"accession":"0001689375-23-000062","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-23-000062","line_url":"/filing/0001689375-23-000062","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":892.0,"shares_display":"892","price_per_share":13.47730235426009,"price_display":"13.48","price_state":"stated","total_value":12021.7537,"total_display":"12,021.75","total_whole":"12,022","shares_owned_after":40058.0,"shares_owned_after_display":"40,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-06","filed_date":"2023-09-06","scope":"insider","n_lines":2},{"id":8617736,"accession":"0001689375-23-000050","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001689375-23-000050","line_url":"/filing/0001689375-23-000050#line-8","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6898.0,"shares_display":"6,898","price_per_share":14.1376,"price_display":"14.14","price_state":"stated","total_value":97521.1648,"total_display":"97,521.16","total_whole":"97,521","shares_owned_after":27130.0,"shares_owned_after_display":"27,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-04","filed_date":"2023-08-04","scope":"insider"},{"id":8617731,"accession":"0001689375-23-000050","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001689375-23-000050","line_url":"/filing/0001689375-23-000050#line-6","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9464.0,"shares_display":"9,464","price_per_share":14.7432,"price_display":"14.74","price_state":"stated","total_value":139529.6448,"total_display":"139,529.64","total_whole":"139,530","shares_owned_after":27130.0,"shares_owned_after_display":"27,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-03","filed_date":"2023-08-04","scope":"insider"},{"id":8617727,"accession":"0001689375-23-000050","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-23-000050","line_url":"/filing/0001689375-23-000050","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10348.0,"shares_display":"10,348","price_per_share":15.188286432160805,"price_display":"15.19","price_state":"stated","total_value":157168.388,"total_display":"157,168.39","total_whole":"157,168","shares_owned_after":28198.0,"shares_owned_after_display":"28,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-02","filed_date":"2023-08-04","scope":"insider","n_lines":3},{"id":8048895,"accession":"0001689375-23-000011","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-23-000011","line_url":"/filing/0001689375-23-000011","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1641.0,"shares_display":"1,641","price_per_share":10.564305423522242,"price_display":"10.56","price_state":"stated","total_value":17336.0252,"total_display":"17,336.03","total_whole":"17,336","shares_owned_after":41494.0,"shares_owned_after_display":"41,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-03","scope":"insider","n_lines":2},{"id":8757049,"accession":"0001689375-23-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000001","line_url":"/filing/0001689375-23-000001#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5200.0,"shares_display":"5,200","price_per_share":13.4484,"price_display":"13.45","price_state":"stated","total_value":69931.68,"total_display":"69,931.68","total_whole":"69,932","shares_owned_after":15516.0,"shares_owned_after_display":"15,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-30","filed_date":"2023-01-03","scope":"insider"},{"id":6872068,"accession":"0001689375-22-000039","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001689375-22-000039","line_url":"/filing/0001689375-22-000039","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4960.0,"shares_display":"4,960","price_per_share":21.907038467741934,"price_display":"21.91","price_state":"stated","total_value":108658.9108,"total_display":"108,658.91","total_whole":"108,659","shares_owned_after":20716.0,"shares_owned_after_display":"20,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-27","scope":"insider","n_lines":2},{"id":6872058,"accession":"0001689375-22-000039","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-22-000039","line_url":"/filing/0001689375-22-000039","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8040.0,"shares_display":"8,040","price_per_share":20.881814975124378,"price_display":"20.88","price_state":"stated","total_value":167889.7924,"total_display":"167,889.79","total_whole":"167,890","shares_owned_after":23814.0,"shares_owned_after_display":"23,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-27","scope":"insider","n_lines":3},{"id":6611403,"accession":"0001689375-22-000033","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001689375-22-000033","line_url":"/filing/0001689375-22-000033#line-7","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3122.0,"shares_display":"3,122","price_per_share":15.2497,"price_display":"15.25","price_state":"stated","total_value":47609.5634,"total_display":"47,609.56","total_whole":"47,610","shares_owned_after":20716.0,"shares_owned_after_display":"20,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-28","scope":"insider"},{"id":6611398,"accession":"0001689375-22-000033","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001689375-22-000033","line_url":"/filing/0001689375-22-000033#line-5","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2403.0,"shares_display":"2,403","price_per_share":15.3096,"price_display":"15.31","price_state":"stated","total_value":36788.9688,"total_display":"36,788.97","total_whole":"36,789","shares_owned_after":20716.0,"shares_owned_after_display":"20,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-27","filed_date":"2022-09-28","scope":"insider"},{"id":6611393,"accession":"0001689375-22-000033","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-22-000033","line_url":"/filing/0001689375-22-000033","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3068.0,"shares_display":"3,068","price_per_share":15.32908109517601,"price_display":"15.33","price_state":"stated","total_value":47029.6208,"total_display":"47,029.62","total_whole":"47,030","shares_owned_after":21016.0,"shares_owned_after_display":"21,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-26","filed_date":"2022-09-28","scope":"insider","n_lines":2},{"id":6872045,"accession":"0001689375-22-000030","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-22-000030","line_url":"/filing/0001689375-22-000030#line-4","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":939.0,"shares_display":"939","price_per_share":15.0871,"price_display":"15.09","price_state":"stated","total_value":14166.7869,"total_display":"14,166.79","total_whole":"14,167","shares_owned_after":20716.0,"shares_owned_after_display":"20,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-23","filed_date":"2022-09-23","scope":"insider"},{"id":6872039,"accession":"0001689375-22-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000030","line_url":"/filing/0001689375-22-000030#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3341.0,"shares_display":"3,341","price_per_share":15.0833,"price_display":"15.08","price_state":"stated","total_value":50393.3053,"total_display":"50,393.31","total_whole":"50,393","shares_owned_after":20716.0,"shares_owned_after_display":"20,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-23","scope":"insider"},{"id":6283976,"accession":"0001689375-22-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000026","line_url":"/filing/0001689375-22-000026#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106.0,"shares_display":"106","price_per_share":15.0134,"price_display":"15.01","price_state":"stated","total_value":1591.4204,"total_display":"1,591.42","total_whole":"1,591","shares_owned_after":20716.0,"shares_owned_after_display":"20,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-19","scope":"insider"},{"id":6163231,"accession":"0001689375-22-000020","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-22-000020","line_url":"/filing/0001689375-22-000020#line-4","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":15.0669,"price_display":"15.07","price_state":"stated","total_value":12053.52,"total_display":"12,053.52","total_whole":"12,054","shares_owned_after":20716.0,"shares_owned_after_display":"20,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-09","filed_date":"2022-09-12","scope":"insider"},{"id":6163226,"accession":"0001689375-22-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000020","line_url":"/filing/0001689375-22-000020#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001741850","owner_name":"KREHER NERISSA","owner_display_name":"KREHER NERISSA","owner_url":"/insider/0001741850","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1221.0,"shares_display":"1,221","price_per_share":15.1333,"price_display":"15.13","price_state":"stated","total_value":18477.7593,"total_display":"18,477.76","total_whole":"18,478","shares_owned_after":20716.0,"shares_owned_after_display":"20,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001509261","name":"Rezolute, Inc.","url":"/issuer/0001509261","role":"Director","n_filings":1,"first_seen":"2025-06-23","last_seen":"2025-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001689375","name":"Entrada Therapeutics, Inc.","url":"/issuer/0001689375","role":"Officer (Chief Medical Officer)","n_filings":9,"first_seen":"2022-09-12","last_seen":"2023-09-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001741850","retrieved_at":"2026-08-24T19:10:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}